CELU
CELU
NASDAQ · Biotechnology

Celularity Inc-A

$0.68
-0.07 (-8.81%)
As of Nov 12, 10:16 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,713.7% upside
Low Target $7.12
Average Target $12.42
High Target $14.14
Current Price $0.68
Current
$0.68
Target
$12.42
$7.12 $12.42 avg $14.14
Scenario Analysis
Bear Case
$7.12
939.7%
Low target
Base Case
$12.42
+1,713.7%
Avg target
Bull Case
$14.14
+1,964.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.55
-73.1% from high
52-Week Low
$0.56
+22.3% from low
Target vs 52W High
$12.42
+387.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.1%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%